First Regioselective Enzymatic Alkoxycarbonylation of Primary Amines. Synthesis of Novel 5′- and 3′-Carbamates of Pyrimidine 3′,5′-Diaminonucleoside Derivatives Including BVDU Analogues

Journal of Organic Chemistry

Volumn 69, Issue 5, 2004, Pages 1748-1751

  Lavandera, Irán ^a   Fernández, Susana ^a   Ferrero, Miguel ^a   Gotor, Vicente ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATES; CARBONYLATION; CATALYSIS; ENZYME IMMOBILIZATION; ENZYMES; SYNTHESIS (CHEMICAL);

ALKOOXYCARBONYLATION; REGIOISOMERS;

AMINES;

5 (2 BROMOVINYL) 2' DEOXYURIDINE; AMINE; CARBAMIC ACID DERIVATIVE; PYRIMIDINE 3',5' DIAMINONUCLEOSIDE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; BURKHOLDERIA CEPACIA; CANDIDA ANTARCTICA; CARBONYLATION; CATALYSIS; ENZYME IMMOBILIZATION; ENZYME MECHANISM; ENZYME SYNTHESIS; STEREOCHEMISTRY;

AMINES; BROMODEOXYURIDINE; CARBAMATES; ENZYMES, IMMOBILIZED; LIPASE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; NUCLEOSIDES; PYRIMIDINES; STEREOISOMERISM;

EID: 1442299906     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo035678m     Document Type: Article

References (33)

1. (a) Faber, K. Biotransformations in Organic Chemistry, 4th ed.; Springer: Berlin, 2000.
2. (b) Bornscheuer, U. T.; Kazlauskas, R. J. Hydrolases in Organic Synthesis; Weinheim: Wiley-VCH: 1999.
3. Gotor, V. Bioorg. Med. Chem. Lett. 1999, 7, 2189-2197.
4. Parrish, J. P.; Salvatore, R. N.; Jung, K. W. Tetrahedron 2000, 56, 8207-8237.
5. Pozo, M.; Pulido, R.; Gotor, V. Tetrahedron 1992, 48, 6477-6484.
6. (a) Pulido, R.; Gotor, V. Carbohydr. Res. 1994, 252, 55-68.
7. (b) Pulido, R.; Gotor, V. J. Chem. Soc., Perkin Trans. 1 1993, 589-592.
8. (a) Morís, F.; Gotor, V. J. Org. Chem. 1992, 57, 2490-2492.
9. (b) Morís, F.; Gotor, V. Tetrahedron 1992, 48, 9869-9876.
10. (a) Díaz, M.; Gotor-Fernández, V.; Ferrero, M.; Fernández, S.; Gotor, V. J. Org. Chem. 2001, 66, 4227-4232.
11. (b) Gotor-Fernández, V.; Ferrero, M.; Fernández, S.; Gotor, V. J. Org. Chem. 1999, 64, 7504-7510.
12. (c) Ferrero, M.; Fernández, S.; Gotor, V. J. Org. Chem. 1997, 62, 4358-4363.
13. (a) Takayama, S.; Lee, S. T.; Hung, S.-C.; Wong, C.-H. Chem. Commun. 1999, 127-128.
14. (b) Orsat, B.; Alper, P. B.; Moree, W.; Mak, C.-P.; Wong, C.-H. J. Am. Chem. Soc. 1996, 118, 712-713.
15. (a) Galmarini, C. M. Electron. J. Oncol. 2002, 1, 22-32.
16. (b) Robins, R. K.; Revankar, G, R. In Antiviral Drug Development; De Clercq, E., Walker, R. T., Eds.; Plenum Press: New York, 1998; p 11.
17. (c) Mansour, T. S.; Storer, R. Curr. Pharm. Des. 1997, 3, 227-264.
18. (a) Czernecki, S.; Valery, J. M. In Carbohydrates in Drug Design; Witczak, Z. J., Nieforth, K. A., Eds.; Dekker: New York, 1997; p 495.
19. (b) De Clercq, E. Pyrimidine Nucleoside Analogues as Antiviral Agents. NATO AS1 Ser., Ser. A 1984; 73, 203-230.
20. Plunkett, W.; Gandhi, V. Cancer Chemother. Biol. Response Modif. Annu. 2001, 19, 21-45.
21. (a) De Clercq, E. Biochem. Pharmacol. 1984, 33, 2159-2169.
22. (b) De Clercq, E.; Descamps, J.; De Somer, P.; Barr, P. J.; Jones, A. S. ; Walker, R. T. Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 2947-2951.
23. (a) Ferrero, M.; Gotor, V. Chem. Rev. 2000, 100, 4319-4347.
24. (b) Ferrero, M.; Gotor V. Monatsh. Chem. 2000, 131, 585-616.
25. (a) Lavandera, I.; Fernández, S.; Ferrero, M.; De Clercq, E.; Gotor, V. Nucleosides Nucleotides Nucleic Acids 2003, 22, 1939-1952.
26. (b) Lavandera, I.; Fernández, S.; Ferrero, M.; Gotor, V. J. Org. Chem. 2001, 66, 4079-4082.
27. To see an explanation for this effect: Lavandera, I.; Fernández, S.; Ferrero, M.; Gotor, V. Tetrahedron 2003, 59, 5449-5456.
28. Detailed conditions: corresponding diaminonucleosides 1-3 and homocarbonates were dissolved in THF/Py (for 1) or THF (for 2 and 3) at 60 °C during 8 days and no reactions were observed.
29. The low reactivity of this carbonate has already been reported in the ref 8.
30. Dangles, O.; Guibé, F.; Balavoine, G.; Lavielle, S.; Marquet, A. J. Org. Chem. 1987, 52, 4984-4993.
31. The antiviral assays are being performed in the Rega Institute for Medical Research (Lovaina, Belgium) by Prof. Erik De Clercq.
32. Lavandera, I.; Fernández, S.; Ferrero, M.; De Clercq, E.; Gotor, V. Nucleosides Nucleotides Nucleic Acids 2003, 22, 833-836.
33. Structures of compounds 10-12 are labeled as follows: diagram presented